119th Congress · SENATE BILLBILL

S. 4109 — Stem Cell Therapeutic and Research Reauthorization Act of 2026

Health
Introduced Mar 17, 2026
Last action Jun 22, 2026
Pipeline · Bill → Law
Step 1
Introduced
Mar 17, 2026
Step 2
Referred
Mar 17, 2026
HELP
Step 3
Committee
Jun 17, 2026
Reported out
Step 4
Senate
Jun 22, 2026
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. The bill also expands periodic reviews of the state of stem cell science to specifically include a review of the use of hi...

Provisions · 3 sectionsReported to Senate
2 versions
Reported to Senate · 3 provisions
AmendmentAI
Amendment
Timeline · 6 actions
Jun 22, 2026
Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Jun 22, 2026
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Jun 17, 2026
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Mar 17, 2026
Introduced in Senate
Mar 17, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 17, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093)